nipah
viru
niv
emerg
zoonot
viru
transmit
bat
human
pig
caus
sever
respiratori
diseas
often
fatal
enceph
antibodi
direct
nivglycoprotein
g
protein
known
play
major
role
clear
niv
infect
provid
vaccineinduc
protect
immun
recent
cell
also
shown
involv
recoveri
niv
infect
far
rel
littl
known
role
cell
respons
antigen
target
nivg
recogn
cell
studi
nivg
protein
serv
target
immunogen
activ
nivspecif
cellular
immun
respons
modifi
vaccinia
viru
ankara
mva
safetytest
strain
vaccinia
viru
preclin
clinic
vaccin
research
use
gener
mvanivg
candid
vaccin
express
differ
version
recombin
nivg
overlap
peptid
cover
entir
nivg
protein
use
identifi
major
histocompat
complex
class
iiirestrict
cell
respons
type
interferon
receptordefici
mice
vaccin
mvanivg
candid
vaccin
identifi
nonam
peptid
epitop
cell
antigen
cell
antigen
nivg
protein
identif
epitop
avail
mvanivg
candid
vaccin
help
evalu
nivgspecif
immun
respons
potenti
immun
correl
vaccinemedi
protect
appropri
murin
model
nivg
infect
note
solubl
version
nivg
advantag
activ
nivgspecif
cellular
immun
respons
use
peptid
first
time
niv
emerg
southern
india
two
strain
niv
identifi
malaysia
bangladesh
strain
share
sequenc
homolog
niv
caus
sever
respiratori
diseas
enceph
averag
case
fatal
rate
cfr
moreov
longterm
neurolog
sequela
even
relaps
enceph
observ
mani
survivor
infect
strain
niv
natur
reservoir
niv
hendra
viru
hev
fruit
bat
genu
pteropu
wide
distribut
asia
australasia
part
africa
moreov
niv
broad
speci
tropism
caus
diseas
mani
anim
speci
niv
infect
human
via
sever
rout
includ
consumpt
food
contamin
bat
secret
transmiss
amplif
host
pig
direct
humantohuman
transmiss
close
contact
current
licens
treatment
prevent
vaccin
avail
use
human
make
develop
effect
prophylact
measur
imper
evid
date
indic
henipaviru
glycoprotein
g
highli
promis
target
virusneutr
antibodi
counteract
infect
highli
pathogen
henipavirus
g
glycoprotein
niv
hev
share
amino
acid
sequenc
homolog
type
ii
transmembran
protein
glycoprotein
virus
bind
host
cell
receptor
highli
conserv
across
mani
speci
date
promis
therapeut
approach
henipaviru
infect
one
base
applic
experiment
human
monoclon
antibodi
bind
receptorbind
site
glycoprotein
hev
hevg
niv
nivg
protect
efficaci
success
evalu
differ
preclin
model
includ
ferret
african
green
monkey
agm
current
sever
vaccin
deliv
nivg
shown
protect
lethal
challeng
infect
preclin
test
candid
vaccin
includ
recombin
virus
develop
use
vaccinia
viru
canarypox
vesicular
stomat
viru
vsv
rabi
viru
measl
viru
adenoviru
platform
date
licens
henipaviru
vaccin
equin
vaccin
hev
equivac
hev
approv
use
hors
australia
vaccin
subunit
vaccin
compris
solubl
form
hevg
hevsg
subunit
hevsg
vaccin
shown
protect
niv
cat
ferret
nonhuman
primat
pig
abil
hevsg
protect
niv
infect
anim
model
warrant
evalu
vaccin
contain
solubl
form
niv
glycoprotein
g
role
antibodi
protect
immun
niv
infect
wide
report
howev
limit
inform
nivspecif
tcellmedi
immun
consequ
interest
better
understand
role
cell
vaccineinduc
protect
niv
turn
aid
develop
new
improv
vaccin
candid
studi
investig
recombin
modifi
vaccinia
viru
ankara
mva
deliveri
nivg
antigen
construct
two
mvanivg
vaccin
candid
express
fulllength
nivg
solubl
form
nivsg
candid
vaccin
genet
stabl
effici
replic
primari
chicken
embryo
fibroblast
cell
cultur
system
use
manufactur
mva
vaccin
importantli
vaccin
mice
lack
interferon
alphabeta
receptor
elicit
readili
detect
nivgspecif
cell
identifi
potenti
epitop
nivg
stimul
antigenspecif
cell
potenti
epitop
stimul
antigenspecif
cell
interestingli
comparison
fulllength
nivg
solubl
antigen
nivsg
induc
significantli
stronger
epitopespecif
cell
respons
work
relev
futur
studi
character
nivgspecif
cell
respons
niv
preclin
model
materi
method
mice
backcross
background
bred
specifiedpathogenfre
spf
condit
hous
isol
cage
unit
isocag
tecniplast
nipah
viru
niv
emerg
zoonot
pathogen
global
concern
rank
recent
world
health
organ
highprior
pathogen
niv
negativesens
singlestrand
rna
viru
member
genu
henipaviru
famili
paramyxovirida
niv
first
identifi
larg
outbreak
affect
human
pig
malaysia
singapor
onward
season
outbreak
observ
almost
annual
bangladesh
sporad
germani
access
food
water
ad
libitum
experi
approv
govern
upper
bavaria
munich
germani
perform
complianc
german
anim
welfar
act
primari
chicken
embryo
fibroblast
cef
isol
spf
chicken
embryo
valo
cuxhaven
germani
grown
minimum
essenti
medium
mem
sigmaaldrich
taufkirchen
germani
supplement
heatinactiv
fetal
bovin
serum
fb
sigmaaldrich
penicillinstreptomycin
sigmaaldrich
mem
nonessenti
amino
acid
solut
sigmaaldrich
human
hela
cell
atcc
maintain
mem
supplement
heatinactiv
fb
sigmaaldrich
antibiot
cell
atcc
grown
vle
dulbecco
modifi
eagl
medium
dmem
merck
darmstadt
germani
supplement
heatinactiv
fb
sigmaaldrich
penicillinstreptomycin
sigmaaldrich
mem
nonessenti
amino
acid
solut
sigmaaldrich
hepe
solut
sigmaaldrich
cell
maintain
c
humidifi
co
atmospher
cdna
encod
entir
amino
acid
sequenc
nivg
protein
nipah
viru
isol
genbank
access
number
modifi
silico
introduc
silent
codon
alter
remov
termin
signal
vaccinia
viru
earli
transcript
tttttnt
gc
nucleotid
run
construct
solubl
form
nivg
protein
nivsg
cytoplasm
transmembran
domain
delet
intern
leader
sequenc
amino
acid
linker
sequenc
ad
describ
previous
vaccinia
viru
vacv
specif
transcript
regul
place
nivsg
gene
sequenc
control
synthet
vacv
earlyl
promot
use
strong
natur
earli
vacv
promot
pvgf
express
nivg
sequenc
cdna
encod
nivg
nivsg
includ
cleavag
site
restrict
endonucleas
xhol
apal
gener
dna
synthesi
genewiz
leipzig
germani
cdna
sequenc
clone
mva
transfer
plasmid
direct
insert
heterolog
sequenc
site
open
read
frame
orf
essenti
viral
gene
recombin
mva
virus
express
nivsg
nivg
protein
gener
describ
previous
summar
cef
cell
confluenc
infect
nonrecombin
mva
clonal
isol
mva
multipl
infect
moi
transfect
vector
plasmid
dna
contain
nivsg
nivg
gene
sequenc
use
hp
dna
transfect
reagent
roch
diagnost
penzberg
germani
h
incub
cell
harvest
recombin
virus
mvanivsg
mvanivg
clonal
isol
screen
coexpress
fluoresc
protein
marker
gfp
plaqu
passag
sever
time
result
vector
viru
isol
qualiti
control
use
standard
protocol
polymeras
chain
reaction
pcr
analysi
genom
viral
dna
serv
confirm
genet
ident
genom
stabil
mva
vector
virus
replic
capac
recombin
mvaniv
virus
compar
nonrecombin
mva
test
multistep
growth
experi
cef
human
hela
cell
gener
vaccin
prepar
recombin
mvaniv
virus
amplifi
cef
purifi
ultracentrifug
sucros
cushion
reconstitut
mm
trishcl
buffer
ph
make
stock
prepar
cef
hela
cell
infect
recombin
mvanivsg
mvanivg
virus
moi
cell
infect
mva
moi
inocul
medium
alon
mock
use
control
cell
lysat
prepar
cultur
supernat
collect
variou
time
point
infect
store
c
cellassoci
secret
protein
resolv
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
electrophoresi
sdspage
protein
transfer
onto
nitrocellulos
membran
wet
electroblot
investig
glycosyl
pattern
protein
pretreat
use
protein
deglycosyl
mix
ii
kit
new
england
biolab
ipswich
usa
accord
manufactur
instruct
prior
sd
page
membran
block
block
buffer
consist
pb
contain
nonfat
dri
milk
powder
carl
roth
karlsruh
germani
vv
tween
sigmaaldrich
one
hour
room
temperatur
membran
probe
primari
antibodi
polyclon
mous
antinivg
polyclon
rabbit
antinivg
dilut
block
buffer
overnight
c
membran
wash
three
time
pb
contain
tween
pbst
probe
goat
antimous
igg
conjug
horseradish
peroxidas
hrp
agil
dako
glostrup
denmark
goat
antirabbit
igg
hrp
cell
signal
technolog
leiden
netherland
membran
wash
pbst
develop
use
supersign
west
dura
extend
durat
substrat
thermo
fisher
scientif
planegg
gemani
blot
visual
use
microchemi
imag
dnr
bioimag
system
neve
yamin
israel
confluent
monolay
hela
cell
infect
recombin
mvanivsg
mvanivg
virus
moi
control
includ
mva
moi
inocul
medium
alon
mock
infect
cell
incub
h
c
incub
cell
fix
paraformaldehyd
pfa
sigmaaldrich
occas
permeabil
triton
sigmaaldrich
cell
block
block
buffer
contain
bovin
serum
albumin
bsa
sigmaaldrich
cell
stain
polyclon
rabbit
antinivg
dilut
pb
contain
bsa
pbsbsa
cell
wash
pb
stain
secondari
antibodi
goat
antimous
igg
alexa
fluor
af
thermo
fisher
scientif
dilut
pbsbsa
buffer
fluoresc
visual
use
keyenc
microscop
keyenc
osaka
japan
mice
immun
pfu
vaccin
buffer
mm
tri
mm
nacl
ph
recombin
mvanivsg
recombin
mvanivg
mva
vaccin
buffer
mock
vaccin
control
via
intraperiton
intramuscular
rout
mice
receiv
either
one
prime
two
primeboost
immun
day
interv
cell
analysi
mice
euthan
day
immun
blood
collect
day
coagul
blood
centrifug
g
min
minicollect
vial
greiner
bioon
alphen
aan
den
rijn
netherland
order
separ
serum
subsequ
store
c
use
antigenspecif
igg
respons
induc
immun
vaccin
candid
analyz
enzymelink
immunosorb
assay
elisa
use
purifi
solubl
recombin
niv
glycoprotein
g
express
mammalian
cell
flat
bottom
elisa
plate
plate
thermo
scientif
coat
ngwell
recombin
protein
volum
incub
overnight
c
plate
wash
three
time
pbst
plate
block
block
buffer
contain
bovin
serum
albumin
sigmaaldrich
sucros
sigmaaldrich
pb
h
c
plate
wash
pbst
describ
sera
serial
dilut
pb
contain
bsa
pbsbsa
threefold
plate
start
dilut
volumewel
incub
h
c
wash
plate
incub
goat
antimous
igg
conjug
hrp
agil
dako
denmark
dilut
pbsbsa
h
c
plate
wash
pbst
describ
earlier
tetramethylbenzidin
tmb
liquid
substrat
system
elisa
sigmaaldrich
ad
plate
incub
color
chang
observ
reaction
stop
addit
stop
reagent
tmb
substrat
nm
sigmaaldrich
absorb
measur
elisa
plate
reader
nm
nm
refer
wavelength
total
igg
titer
calcul
inflect
point
titrat
curv
logarithm
reciproc
protein
sequenc
nivg
obtain
uniprot
databas
id
use
silico
approach
identifi
individu
synthet
peptid
span
extern
domain
nivg
protein
start
third
amino
acid
ntermin
side
c
terminu
amino
acid
peptid
librari
consist
peptid
overlap
peptid
synthes
thermo
fisher
scientif
crude
materi
puriti
mg
scale
twodimension
peptid
pool
matrix
system
use
screen
briefli
peptid
organ
twodimension
matrix
peptid
pool
contain
peptid
map
potenti
cell
epitop
posit
peptid
everi
possibl
sequenc
peptid
length
determin
theoret
peptid
analyz
bind
mous
major
histocompat
complex
mhc
class
allel
use
syfpeithi
databas
peptid
amino
acid
sequenc
length
synthes
test
identif
cell
epitop
mhc
class
ii
bind
predict
perform
peptid
found
within
posit
peptid
pool
identifi
enzymelink
immunospot
assay
elispot
use
mhc
class
ii
bind
cell
epitop
predict
resourc
immun
epitop
databas
iedb
http
wwwiedborg
peptid
restrict
mous
mhc
class
ii
allel
analyz
use
iedb
recommend
predict
method
promis
candid
chosen
experiment
epitop
predict
studi
peptid
dissolv
concentr
mgml
pb
aliquot
store
c
use
cell
analysi
elispot
perform
describ
previous
briefli
spleen
collect
mice
day
final
immun
singlecel
suspens
prepar
teas
spleen
cell
strainer
falcon
corn
corn
ny
usa
red
blood
cell
rbc
remov
use
red
cell
lysi
buffer
sigmaaldrich
cell
wash
resuspend
consist
sigmaaldrich
contain
heatinactiv
fb
sigmaaldrich
penicillinstreptomycin
sigmaaldrich
experi
requir
cell
purif
splenocyt
incub
mous
microbead
miltenyi
biotec
bergisch
gladbach
germani
process
neg
select
use
quadromac
separ
miltenyi
biotec
cell
measur
elispot
assay
use
mous
elispotplu
kit
mabtech
stockholm
sweden
describ
manufactur
protocol
summari
splenocyt
seed
onto
flat
bottom
plate
sarstedt
germani
peptid
pool
subpool
individu
peptid
ad
peptid
dilut
mix
splenocytepeptid
mixtur
transfer
onto
plate
precoat
detect
antibodi
incub
h
c
nonstimul
cell
use
mock
control
posit
control
cultur
treat
phorbol
myrist
acet
pma
ionomycin
sigmaaldrich
vaccinia
viru
vacv
specif
cell
epitop
tsykfesv
incub
plate
process
describ
kit
manufactur
protocol
mabtech
spot
count
analyz
use
autom
elispot
plate
reader
el
vi
eliscan
el
vi
elispot
analysi
softwar
hannov
germani
splenocyt
dilut
cellsml
cell
ad
onto
ubottom
plate
peptid
dilut
ad
give
final
peptid
concentr
vacv
cell
epitop
final
concentr
use
posit
control
along
pma
ngml
plu
ionomycin
ngml
pb
dilut
use
mock
stimul
control
plate
cell
incub
h
c
brefeldin
golgi
inhibitor
prepar
dilut
brefeldin
biolegend
san
diego
ca
usa
ad
give
final
dilut
brefeldin
cell
incub
addit
h
c
incub
plate
centrifug
g
min
supernat
remov
sampl
filter
nylon
mesh
sefar
pti
ltd
huntingwood
nsw
australia
ml
round
bottom
fac
tube
sarstedt
singlecolor
control
prepar
fac
analysi
use
onecomp
compens
bead
ebiosci
thermo
fisher
scientif
fluorophoreconjug
antibodi
cell
viabil
dye
zombi
aqua
data
acquisit
perform
macsquant
vyb
flow
analys
miltenyi
biotec
data
analyz
use
flowjo
flowjo
llc
bd
life
scienc
ashland
usa
data
analyz
use
graphpad
prism
version
graphpad
softwar
inc
san
diego
ca
usa
express
mean
standard
error
mean
sem
statist
analysi
perform
use
unpair
twotail
ttest
compar
two
group
oneway
anova
compar
three
group
threshold
statist
signific
p
gener
recombin
mva
virus
deliv
nivg
antigen
use
gene
niv
malaysia
isol
genbank
access
number
gener
codonoptim
gene
sequenc
encod
fulllength
glycoprotein
g
nivg
solubl
extern
domain
g
protein
nivsg
synthet
gene
sequenc
place
transcript
control
vaccinia
virusspecif
promot
pvgf
introduc
mva
genom
homolog
recombin
target
intergen
site
essenti
mva
gene
clonal
isol
recombin
virus
mvanivsg
mvanivg
facilit
coproduct
green
fluoresc
report
protein
gfp
previous
describ
final
recombin
virus
contain
nivg
gene
sequenc
mvanivg
mvanivsg
obtain
remov
gfp
report
gene
intragenom
homolog
recombin
figur
marker
gene
delet
verifi
ident
desir
modif
perform
standard
qualiti
control
experi
describ
previous
pcr
analysi
viral
genom
dna
confirm
proper
insert
recombin
gene
sequenc
target
site
genom
mva
figur
genet
characterist
stabil
recombin
mva
virus
assess
growth
behavior
recombin
virus
mvanivsg
mvanivg
multistep
growth
analys
human
hela
cell
primari
cef
routin
use
amplif
recombin
mva
vaccin
manufactur
figur
mvanivsg
mvanivg
effici
replic
cef
demonstr
increas
infect
titer
compar
obtain
nonrecombin
mva
howev
mvanivg
mvanivsg
product
grow
human
hela
cell
confirm
retain
characterist
replic
defici
mva
cell
mammalian
origin
find
corrobor
expect
mva
phenotyp
confirm
recombin
virus
could
handl
laboratori
condit
biosafeti
level
note
origin
gener
anoth
recombin
mva
viru
use
synthet
earlyl
promot
transcript
control
recombin
gene
express
product
fulllength
nivg
protein
howev
upon
growth
test
candid
viru
fail
reach
level
infecti
progeni
cef
elig
largescal
amplif
need
vaccin
product
process
vaccin
candid
mvanivsg
mvanivg
produc
recombin
niv
glycoprotein
g
fulllength
form
nivg
parallel
solubl
form
nivsg
nivg
amino
acid
long
protein
consist
ntermin
intern
domain
transmembran
domain
ctermin
extern
domain
figur
nivsg
protein
intern
leader
sequenc
three
amino
acid
linker
replac
intern
transmembran
domain
figur
describ
previous
assess
correct
express
studi
cellular
local
nivg
nivsg
immunofluoresc
microscopi
mvanivinfect
cell
immunolabel
antinivg
antibodi
follow
fluoresc
label
secondari
antibodi
cell
nuclei
stain
dapi
nm
anticip
observ
differ
pattern
green
fluoresc
vari
cellular
local
depend
mvaniv
construct
green
fluoresc
specif
nivg
identifi
permeabil
nonpermeabil
cell
infect
mvanivg
figur
mvainfect
mock
control
cell
data
confirm
recombin
fulllength
nivg
protein
encod
mvanivg
inde
anchor
cell
surfac
contrast
nivgspecif
stain
cell
infect
mvanivsg
viru
appear
predominantli
locat
within
cell
readili
detect
permeabil
anticip
fail
detect
nivsg
consider
amount
without
permeabil
confirm
nivsg
express
cell
surfac
figur
investig
synthesi
nivg
protein
infect
mvanivsg
mvanivg
respect
total
protein
infect
cef
hela
cell
cultur
analyz
western
blot
use
nivgspecif
antibodi
total
cell
lysat
cultur
supernat
obtain
cef
hela
cultur
infect
recombin
mva
viru
separ
sdspage
immunoblot
specif
detect
protein
estim
molecular
mass
approxim
kda
lysat
cef
cell
hela
cell
infect
either
mvanivg
mvanivsg
figur
cell
lysat
glycoprotein
first
detect
h
postinfect
sinc
nivsg
gene
encod
sequenc
modifi
result
secret
solubl
version
sg
perform
addit
western
blot
experi
determin
whether
protein
still
maintain
glycosyl
site
compar
wildtyp
nivg
lysat
supernat
obtain
cultur
cell
infect
mvanivsg
treat
enzym
deglycosyl
protein
analyz
western
blot
enzym
treatment
result
reduct
molecular
mass
recombin
nivsg
protein
kda
kda
figur
match
expect
size
unmodifi
g
protein
suggest
recombin
nivsg
retain
normal
glycosyl
pattern
wildtyp
nivg
assess
immunogen
recombin
mvanivgnivsg
candid
vaccin
vaccin
mice
pfu
via
intramuscular
rout
day
serum
sampl
test
nivgbind
igg
antibodi
elisa
day
first
immun
prime
day
second
immun
primeboost
figur
even
singl
applic
mvanivg
vaccin
induc
abund
level
nivgspecif
igg
antibodi
mice
booster
immun
vaccin
anim
produc
even
higher
level
circul
nivgspecif
antibodi
antibodi
titer
increas
approxim
tenfold
current
limit
inform
avail
nivspecif
cell
immun
order
character
nivgspecif
cell
respons
induc
candid
vaccin
first
aim
identifi
nivg
polyproteinspecif
cell
epitop
mice
background
mhc
mhc
ii
immun
twice
mvanivsg
candid
vaccin
via
intraperiton
ip
rout
splenocyt
prepar
day
final
inocul
cell
purifi
restimul
overlap
peptid
correspond
nivg
protein
pool
overlap
peptid
use
twodimension
peptid
matrix
system
figur
screen
abil
induc
elispot
product
background
level
observ
stimul
peptid
pool
test
figur
cell
mice
immun
mvanivsg
mva
mock
group
show
elev
number
spotform
count
sfc
stimul
peptid
pool
figur
next
step
peptid
within
peptid
pool
use
character
cell
epitop
specif
detail
pool
subdivid
subpool
contain
peptid
sinc
two
peptid
share
pool
ytrstdnqavikd
tdnqavikdalqgiq
peptid
also
test
separ
experi
use
ident
immun
protocol
splenic
cell
purif
procedur
cell
mice
restimul
subpool
individu
peptid
stimul
subpool
result
product
background
level
mvanivsg
group
sfc
mean
sem
valu
splenocyt
respect
figur
subpool
howev
stimul
cell
mvanivsg
group
stimul
cell
individu
peptid
present
subpool
result
differ
outcom
product
background
observ
cultur
stimul
mean
cell
mvanivsg
group
data
suggest
peptid
contain
peptid
sequenc
stimul
nivgspecif
cell
nivg
nivsg
current
limit
inform
avail
nivspecif
cell
immun
order
character
nivgspecif
cell
respons
induc
candid
vaccin
first
aim
identifi
nivg
polyproteinspecif
cell
epitop
mice
background
mhc
mhc
ii
immun
twice
mvanivsg
candid
vaccin
via
intraperiton
ip
rout
splenocyt
prepar
day
final
inocul
cell
purifi
restimul
overlap
peptid
correspond
nivg
protein
pool
overlap
peptid
use
twodimension
peptid
matrix
system
figur
screen
abil
induc
elispot
product
background
level
observ
stimul
peptid
pool
test
figur
cell
mice
immun
mvanivsg
mva
mock
group
show
elev
number
spotform
count
sfc
stimul
peptid
pool
figur
next
step
peptid
within
peptid
pool
use
character
cell
epitop
specif
detail
pool
subdivid
subpool
contain
peptid
sinc
two
peptid
share
pool
g
ytrstdnqavikd
g
tdnqavikdalqgiq
peptid
also
test
separ
experi
use
ident
immun
protocol
splenic
cell
purif
procedur
cell
mice
restimul
subpool
individu
peptid
stimul
subpool
result
product
background
level
mvanivsg
group
sfc
mean
sem
valu
splenocyt
respect
figur
subpool
howev
stimul
cell
mvanivsg
group
stimul
cell
individu
peptid
present
subpool
result
differ
outcom
product
background
observ
cultur
stimul
mean
cell
mvanivsg
group
data
suggest
peptid
contain
peptid
sequenc
stimul
nivgspecif
cell
graph
show
sfc
spotform
count
stimul
cell
differ
group
analyz
oneway
anova
asterisk
repres
statist
signific
overal
differ
specif
peptid
subpool
individu
peptid
p
map
potenti
cell
epitop
within
nivg
protein
detail
dissect
peptid
everi
possibl
sequenc
figur
sequenc
analyz
bind
comput
use
syfpeithi
databas
four
best
amino
acid
length
chosen
tabl
test
peptid
immun
mice
twice
mvanivsg
via
ip
rout
analyz
total
splenocyt
activ
elispot
assay
sixteen
overlap
peptid
test
eight
result
stimul
measur
mvanivsg
group
figur
posit
peptid
includ
three
length
two
length
two
length
one
length
figur
mean
sfc
valu
lower
cell
stimul
peptid
rel
peptid
mean
valu
mvanivsg
group
cell
peptid
peptid
compar
analysi
posit
peptid
sequenc
demonstr
sequenc
peptid
rstdnqavi
present
posit
peptid
tabl
addit
sequenc
peptid
stdnqavi
present
eight
posit
peptid
character
induct
sfc
peptid
detail
mice
vaccin
twice
via
im
rout
commonli
use
rout
human
vaccin
vitro
stimul
splenocyt
analyz
elispot
assay
experi
chose
promis
peptid
amino
acid
sequenc
length
peptid
six
peptid
test
significantli
stimul
activ
mvanivsg
group
rel
mva
pb
control
figur
mean
sfc
valu
howev
show
statist
signific
variat
individu
peptid
importantli
mean
sfc
valu
peptid
nonsignificantli
elev
rel
peptid
mean
sem
cell
respect
consequ
chose
peptid
rstdnqavi
mean
cell
potenti
epitop
candid
nivg
tabl
align
peptid
full
sequenc
nivg
shown
figur
differ
group
analyz
oneway
anova
asterisk
repres
statist
signific
overal
differ
specif
peptid
p
p
peptid
chosen
promis
peptid
nivg
peptid
chosen
promis
peptid
nivg
row
bold
indic
promis
nivgspecif
cell
epitop
compar
evalu
activ
nivgspecif
immun
im
vaccin
mvanivsg
mvanivg
use
standard
dose
pfu
stimul
splenocyt
peptid
tabl
analyz
cytokin
product
elispot
assay
plu
ic
comparison
two
candid
vaccin
show
mean
sfc
valu
significantli
higher
mvanivsg
group
rel
mvanivg
group
figur
figur
mean
mvanivsg
group
cell
mean
mvanivg
group
cell
figur
ic
data
show
frequenc
absolut
number
cell
significantli
higher
control
background
level
figur
peptid
induc
product
cell
figur
indic
inde
stimul
antigenspecif
cell
compar
two
candid
vaccin
found
percentag
absolut
number
cell
significantli
higher
mvanivsg
group
mean
frequenc
cell
mvanivsg
group
mvanivg
group
mean
absolut
number
cell
rang
splenocyt
splenocyt
mvanivsg
mvanivg
group
respect
taken
togeth
elispot
ic
data
indic
mvanivsg
activ
higher
number
peptidespecif
cell
mvanivg
analyz
coproduct
found
major
nivg
peptidespecif
cell
mvanivsg
mvanivg
immun
mice
doubl
posit
cytokin
figur
show
primeboost
immun
two
vaccin
candid
gener
robust
nivgspecif
cell
respons
test
immunogen
singl
vaccin
mice
vaccin
mvanivsg
mvanivg
mva
mock
via
im
rout
analyz
elispot
ic
describ
elispot
result
overal
show
elev
sfc
count
rel
background
level
mva
mock
control
figur
statist
signific
differ
mvanivsg
mvanivg
detect
mean
sfc
valu
cell
respect
fac
analysi
show
frequenc
absolut
number
cell
higher
experiment
group
rel
mva
mock
control
figur
mean
percentag
cell
mvanivg
group
wherea
mvanivsg
group
mean
percentag
rang
peptid
mvanivg
prime
immun
induc
low
frequenc
cell
mvanivsg
group
show
secret
cell
singl
vaccin
figur
although
percentag
lower
observ
primeboost
immun
figur
indic
prime
immun
mvanivsg
suffici
gener
sizeabl
popul
polyfunct
antigenspecif
cell
tabl
measur
elispot
assay
ic
plu
fac
analysi
b
antigenspecif
cell
respons
induc
primeboost
immun
sfc
stimul
splenocyt
measur
elispot
assay
b
product
stimul
splenic
cell
measur
ic
fac
analysi
graph
show
frequenc
absolut
number
per
splenocyt
antigenspecif
cell
c
antigenspecif
cell
respons
induc
prime
immun
c
sfc
stimul
splenocyt
measur
elispot
assay
frequenc
absolut
number
per
splenocyt
antigenspecif
cell
measur
ic
plu
fac
analysi
differ
individu
group
analyz
oneway
anova
tukey
posthoc
test
asterisk
repres
statist
signific
differ
two
group
p
p
p
initi
also
analyz
purifi
cell
cultur
mvanivsg
immun
mice
abil
stimul
elispot
use
twodimension
pooledpeptid
matrix
system
figur
section
contrast
cellenrich
splenocyt
sfc
signal
cultur
lower
figur
order
determin
definit
peptid
pool
background
level
select
cut
valu
cell
figur
grey
line
mean
sfc
valu
background
observ
pool
pool
figur
order
identifi
potenti
cell
epitop
perform
comput
analysi
peptid
five
posit
peptid
pool
measur
elispot
assay
pool
use
mhc
ii
bind
predict
obtain
iedb
onlin
resourc
found
two
promis
peptid
peptid
lfmtnvwtppnpntv
nvwtppnpntvyhc
tabl
next
use
ic
identifi
directli
antigenspecif
cell
stimul
peptid
splenocyt
mice
vaccin
mvanivg
mvanivsg
stimul
peptid
analyz
flow
cytometri
small
popul
peptidespecif
cell
observ
mvanivsg
mvanivg
group
figur
due
low
frequenc
cell
chose
cut
valu
differenti
posit
signal
background
overal
cell
mvanivsg
group
frequenc
cut
rel
mvanivg
group
figur
mean
percentag
cell
two
peptid
mvanivsg
mvanivg
respect
moreov
frequenc
absolut
number
cell
peptid
stimul
cultur
significantli
higher
mvanivsg
group
compar
mvanivg
group
mean
splenocyt
respect
peptid
mvanivsg
vaccin
mice
show
significantli
elev
frequenc
cell
conclus
data
indic
peptid
nvwtppnpntvyhc
promis
cell
epitop
candid
nivg
align
peptid
full
amino
acid
sequenc
wildtyp
nivg
shown
figur
continu
threat
suddenli
emerg
niv
outbreak
particularli
bangladesh
india
demonstr
need
countermeasur
approach
readi
use
immedi
public
health
respons
present
licens
niv
vaccin
use
human
avail
exist
niv
candid
vaccin
significantli
reduc
risk
infect
transmiss
viru
case
outbreak
scenario
experiment
niv
vaccin
alreadi
test
differ
preclin
anim
model
major
focu
approach
evalu
immunogen
efficaci
context
niv
challeng
infect
studi
efficaci
mostli
associ
gener
nivspecif
antibodi
immun
monitor
mainli
reli
detect
virusneutr
antibodi
howev
rel
littl
known
induct
relev
nivspecif
cellular
immun
respons
context
avail
appropri
tool
investig
role
cell
nivspecif
immun
import
prerequisit
develop
new
vaccin
therapeut
thu
indispens
monitor
anim
model
contribut
virusspecif
cell
protect
immun
also
potenti
niv
antigenspecif
immun
patholog
identifi
major
histocompat
complex
mhc
haplotyp
peptid
epitop
nivg
protein
stimul
cell
vaccin
mice
twodimension
matrix
pool
overlap
peptid
mice
alreadi
establish
valuabl
preclin
anim
model
niv
infect
ld
pfu
intraperiton
challeng
infect
moreov
previou
studi
alreadi
success
demonstr
interferon
type
receptor
knockout
mice
readili
use
anim
model
studi
immunogen
protect
capac
mva
immun
wish
specif
assess
abil
mvadeliv
nivg
antigen
induc
activ
cellular
immun
respons
mice
gener
envelop
g
protein
known
wellconserv
attach
glycoprotein
hev
niv
previou
studi
recombin
adenoassoci
viru
vaccin
express
fulllength
nivg
protein
protect
hamster
niv
infect
model
anoth
approach
solubl
version
hevg
engin
show
even
advantag
efficaci
test
differ
preclin
anim
model
use
hevsg
monoclon
antibodi
deriv
alreadi
success
test
therapeut
approach
human
enhanc
henipaviru
g
proteininduc
immunogen
also
design
test
solubl
version
nivg
protein
nivsg
similar
hevsg
antigen
use
gener
compar
evalu
immunogen
nivsg
protein
also
gener
mva
express
fulllength
g
recombin
virus
mvanivg
mvanivsg
produc
stabl
amount
nivg
antigen
upon
vitro
infect
human
cell
indic
unimpair
express
target
gene
transcript
control
synthet
vaccinia
virusspecif
earlyl
promot
strong
natur
earli
promot
pvgf
case
mvanivsg
remov
transmembran
domain
cytoplasm
tail
result
secret
nivg
mvainfect
cell
accumul
also
supernat
cell
cultur
demonstr
western
blot
analysi
immunostain
similar
result
obtain
hevsg
express
convent
recombin
vacv
contrast
fulllength
mvaproduc
nivg
protein
releas
supernat
indic
stabl
present
cell
surfac
transmembran
domain
anoth
import
aspect
proper
protein
express
fold
conform
stabil
influenc
nglycan
recent
studi
indic
nivg
nglycan
reduc
fusion
effici
remov
nglycan
caus
cellcel
hyperfusogen
increas
viral
entri
glycosidas
treatment
fulllength
mvaproduc
nivg
result
polypeptid
kda
correspond
molecular
mass
predict
niv
g
gene
encod
sequenc
glycosidas
treatment
nivsg
also
indic
presenc
nglycan
site
within
solubl
version
glycoprotein
first
vivo
evalu
mice
reveal
treatment
mvanivg
mvanivsg
candid
vaccin
result
induct
similar
level
gbind
serum
antibodi
confirm
immunogen
antigen
version
context
presenc
bind
antibodi
seem
play
substanti
role
block
niv
entri
sinc
mechan
niv
neutral
complex
involv
antigen
site
requir
simpl
receptor
bind
howev
recent
studi
differ
anim
model
suggest
cellular
immun
respons
also
involv
mediat
protect
niv
infect
observ
support
studi
pig
model
niv
infect
show
substanti
activ
cell
oral
infect
niv
line
preclin
data
human
surviv
niv
infect
show
signific
level
prolifer
cell
indic
presenc
acut
effector
cell
data
emphas
addit
humor
immun
respons
cell
could
associ
recoveri
niv
infect
recent
studi
stroh
cowork
confirm
activ
nivspecif
cell
mice
vaccin
nivlik
particl
data
highlight
cell
may
play
critic
role
niv
infect
anoth
hypothesi
nivspecif
cell
could
involv
potenti
immunopatholog
context
data
infect
neurotrop
virus
exampl
west
nile
viru
demonstr
antigenspecif
cell
open
blood
brain
barrier
contribut
viru
infect
brain
thu
allow
detail
studi
character
cell
nivassoci
immun
pathogenesi
essenti
identifi
nivg
peptid
epitop
allow
specif
mhcrestrict
antigen
present
activ
nivspecif
cell
identifi
nonam
epitop
rstdnqavi
analysi
peptid
sequenc
show
nivg
could
function
conserv
hendra
viru
cedar
viru
anoth
recogn
henipaviru
g
antigen
figur
structur
function
analys
reveal
promiscu
speciesspecif
use
ephrin
receptor
cedar
viru
potenti
epitop
support
detail
experiment
character
cell
induc
niv
infect
mous
model
contribut
pathogenesi
protect
studi
found
mvanivsg
vaccin
induc
significantli
higher
amount
nivg
epitopespecif
cell
compar
mvanivg
candid
vaccin
somewhat
surpris
observ
immun
antigen
elicit
compar
level
gspecif
antibodi
tempt
specul
nivsg
solubl
antigen
trigger
enhanc
cell
respons
avail
two
differ
pathway
antigen
present
one
hand
nivsg
intracellularli
synthet
antigen
endogen
process
present
via
mhci
cell
surfac
activ
cell
addit
nivsg
secret
high
amount
mvanivsginfect
cell
extracellular
antigen
effici
fuel
crosspresent
pathway
therebi
induc
elev
cell
immun
respons
interestingli
mvanivsg
candid
vaccin
also
prove
rapidli
induc
nivg
epitopespecif
cell
singledos
applic
data
relev
sinc
epidemiolog
recent
niv
outbreak
demonstr
potenti
vaccin
candid
rapidli
protect
importantli
epitop
identifi
mice
serv
establish
small
anim
model
niv
infect
addit
show
induct
nivgspecif
cell
upon
primeboost
immun
mvaniv
vaccin
use
peptid
vitro
stimul
identifi
use
mhc
ii
bind
predict
obtain
iedb
onlin
resourc
wwwiedborg
data
goe
well
along
hypothesi
cell
respons
also
significantli
elev
upon
infect
mvanivsg
vaccin
result
effici
activ
cell
respons
experi
need
character
contribut
niv
gspecif
cell
niv
infect
detail
taken
togeth
find
show
activ
nivgspecif
cell
mice
follow
vaccin
mvabas
candid
vaccin
confirm
identif
potenti
nivg
cell
peptid
epitop
studi
also
demonstr
mvanivsg
candid
vaccin
may
superior
immunogen
result
nivspecif
antibodi
cell
mice
data
emphas
promis
futur
studi
anim
model
evalu
role
nivspecif
cell
activ
peptid
epitop
vaccineinduc
protect
potenti
contribut
nivinduc
patholog
supplementari
materi
follow
avail
onlin
http
figur
gener
character
recombin
mvanivsg
mvanivg
figur
product
cell
stimul
nivg
peptid
figur
amino
acid
align
peptid
figur
qualiti
activ
cell
mice
immun
recombin
mva
express
nivg
author
contribut
gk
sv
ccb
gs
av
conceiv
design
experi
gk
sv
sj
av
perform
experi
gk
sv
uk
ccb
gs
av
analyz
data
gk
gs
av
wrote
paper
author
read
agre
publish
version
manuscript
